Drug Companies Get Booster Approval

Vaccine advisers to the U.S. Centers for Disease Control and Prevention (CDC), in a recent meeting, voted unanimously to recommend booster doses of Pfizer’s and Moderna’s COVID-19 vaccine for all adults in the United States six months after their first two shots expire.

Members of the Advisory Committee on Immunization Practices also voted to strengthen the recommendation to say that people 50 and older should get a booster dose of vaccine.

The votes follow the U.S. Food and Drug Administration’s decision earlier on to authorize boosters of the Pfizer and Moderna COVID-19 vaccines for all adults.

Previously, boosters had been authorized for anyone 65 and older who was vaccinated with the Pfizer or Moderna vaccines at least six months ago and for certain adults at high risk of infection or of severe disease.

Readers Bureau, Contributor

Edited by Jesus Chan

Do you want to add feedback to this story? Please add a comment in the box below or send an email to info@thereadersbureau.com,  Call us at 201-500-7715